Rezultati pretraživanja
  1. 31. kol 2019.

    Improving morbidity estimates after using Reporting Guidelines and Clavien's Comprehensive Complication Index®. Honored to publish our work in

  2. What pre info correlate with outcomes? Clin, path, and molecular data in the consecutive Lund RC cohort (~400cases) analyzed. Mol-Subtype and 15 published pos IHC-markers all weak/neg. LVI in TURB best pre-RC predictor of CSS.

  3. 1. srp 2019.

    High volume centres for GU malignancies = greater utilisation of cancer surgery, lower morbidity, better survival outcomes. Mainly for radical . Eur Urol Oncol. 2019 May;2(3):265-273.

  4. 16. tra 2019.

    2 - TURBT with pT1 tumor. carcinoma or not? Reminder: a consideration for pT1 micropapillary carcinoma. I often go back to 2010 AJSP paper for guidance on this issue. 2nd slide for your reference.

    Prikaži ovu nit
  5. 15. svi 2019.

    15 - One more of my “face to face” & also intermingled. Left 👉 (Pap) Nephrogenic Adeno Right 👉 , interestingly creeping into NA 😮 From w/ extensive CIS & multifocal NA, this is at one junction. Felt no need for IHC.

  6. 24. velj 2019.

    Interesting data on Certainly higher than most local hospitals and draft minimum number of 30. Very relevant to ongoing discussions in the West Midlands

  7. 1. ožu 2019.

    Morbidity of Radical can be decreased by 40% if you choose to go to a high-volume center. But centralizing care to the inflection point (50/yr), where the effect of increasing volume does not increase benefit will severely decrease access to care.

    Prikaži ovu nit
  8. 18. sij

    Meeting - . Best of in Europe. Amazing discussions. Intracorporeal diversion in robotic is the trend and most probably the winner in the nearest future

  9. Excellent work by showing UES rate for SPY RCUDs was 0% (0/93 ureters) compared with 7.5% (7/93 ureters) for non-SPY RCUDs (p = 0.01)! Game changer?

  10. Our live surgery webcast continues as and our panel, including experts from , and , discuss the difference between male and female . Watch live and submit your questions:

  11. Do not miss the brand new issue of Featuring in localized , optimal indications for cytoreductive , vs open & intermediate endpoints in high-risk

    Prikaži ovu nit
  12. The latest issue is out, featuring in advanced , trends in for , metastasectomy in , active surveillance in intermediate-risk , and much more! Check it out at

  13. 29. ožu 2019.

    Current guidelines suggest that is the best option for patients who fail BCG, but many patients are unfit or unwilling to undergo . discusses treatment options in this space here:

  14. 12. pro 2018.

    The 2016 AUA guidelines supports standard PLND at the time of as for surgically curable . But does evidence support extended PLND as a surgical standard? Seth P. Lerner, MD, discusses here:

  15. Meet our Top Doc, Dragan Golijanin MD Learn more Dr Golijanin is Director GU Oncology , VP , Co-Dir , a high volume robotic surgeon performing , Partial/Radical Nephrect, NephroU & Salvge

  16. 26. tra 2019.

    The Expansion of the electronic Rapid Fitness Assessment to all aspects of This time; pts aged 75+ s/p at Comprehensive assessment; Precise Insight for pts.

  17. New Systematic Review - Robotic versus open radical for bladder in adults. 5 RCTs, 541 participants. Robotic surgery probably results in fewer blood transfusions & slightly shorter hospital stay vs open .

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.